Medprin Regenerative Medical Technologies Co.,Ltd.’s Net Profit Dropped 6.4% in First Three Quarters of 2022

Medprin Regenerative Medical Technologies Co.,Ltd. (广州迈普再生医学科技股份有限公司) (301033.SZ) reported a net profit of 30 million yuan in the first three quarters of 2022, down 6.4% year-on-year.

Meanwhile, the company posted 139.3 million yuan in revenue, up 34.8% year-on-year.

At the end of the reporting period, it had 767.7 million yuan in total assets and 172.2 million yuan in total liabilities, with a liability-to-asset ratio of 22.4%.